Experience
Wyeth
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Represented Wyeth in multiple separate Hatch-Waxman litigations concerning Effexor XR®, a multibillion dollar antidepressant; the cases were resolved through confidential settlement at various stages of litigation, including in the midst of trial.
Wyeth v. Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd., 2:03-cv-01293, D.N.J., Judges Martini, Hedges
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Eli Lilly and Company
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Pronova Biopharma Norge AS
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
Biogen International GmbH
Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.
Medicis Pharmaceutical Corp.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.